Company Announcements

Notice of AGM and Annual Report and Accounts

Source: RNS
RNS Number : 0537W
Seraphine Group PLC
15 August 2022

15 August 2022

Seraphine Group plc

("Seraphine" or the "Company")

Notice of Annual General Meeting and Annual Report and Accounts

Seraphine Group plc (LON: BUMP), the international digitally-led maternity and nursing wear brand, is pleased to announce that the Notice of its 2022 Annual General Meeting ("Notice of AGM") is now available to view on the Company's website at:

The AGM will be held at 9.30 a.m. on Wednesday, 21 September 2022, at 107 Cheapside, London EC2V 6DN.

Proposed AGM Arrangements

Shareholders may attend the AGM in person and the Company looks forward to engaging with those shareholders who choose to do so.

For shareholders who decide not to attend the AGM in person or who are unable to attend in person, the Company requests that you still cast your votes in respect of the business of the meeting and the details of how to vote are set out in the Notice of AGM.

Participation at the AGM

The board recognises that the AGM provides an important opportunity to engage with shareholders.  Accordingly, shareholders will be afforded a reasonable opportunity to ask questions in person on all the items of business set out in the Notice of AGM during the meeting.

Shareholders will be requested to restrict themselves to two questions or comments initially, and further questions will be considered if time permits. There may not be sufficient time available to address all the comments and questions raised during the meeting.

For further details on the business to be conducted at the AGM, including the details of the resolutions that will be put to the AGM, please refer to the Notice of AGM.

Further, Seraphine has now made available on its website ( the Annual Report and Accounts for the period ended 3 April 2022 (the "FY22 Annual Report").

Copies of the Notice of AGM and the FY22 Annual Report will be posted to shareholders shortly.

In accordance with Listing Rule 9.6.1, copies of the Notice of AGM and of the FY22 Annual Report will be submitted to the FCA's National Storage Mechanism (NSM) and will shortly be available for inspection at

The information included in the final results announcement released by the Company on 1 August 2022 constitutes the materials required by the FCA's Disclosure Guidance and Transparency Rule 6.3.5R.


For further information, please contact:


Seraphine Group plc

David N Williams, CEO

Lee Williams, CFO


via Buchanan

Buchanan Communications

Helen Tarbet

Simon Compton

Kim Looringh van Beeck


+44 (0)20 7466 5000

+44 (0) 7872 604453

+44(0) 7979 497324

+44(0)7477 967446


About Seraphine


Seraphine is an international digitally-led maternity and nursing wear brand with a diverse range of innovative maternity and nursing products serving an under-competed global market.


Seraphine was founded in 2002 with the vision of creating desirable clothes which women would want to wear even if they were not pregnant, and this ethos remains true to this day. The Group has over 18 years' experience designing and developing maternity and nursing wear for women from first trimester to post-partum and nursing products.


The Group has achieved global brand recognition through its rapidly growing digital platform, which in the year to 3 April 2022, contributed to approximately 84% of product revenue. The Group currently exports products to customers in over 120 countries globally, with the Group's largest markets being Europe, North America and the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.